Clostridium Difficile Infection in Children: A Review

Elena Borali1, Costantino De Giacomo

  • 1Paediatrics Division, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy.

Insights

Clostridium difficile (C. diff) infection is an emerging enteric pathogen causing significant health issues in children. This review updates pediatricians on C. diff infections unique to this age group.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Pediatrics

Background:

  • Clostridium difficile (C. diff) is a Gram-positive, anaerobic bacterium causing health care-associated diarrhea.
  • Historically considered a colonizer in children, C. diff is increasingly recognized as a significant pathogen in pediatric populations.
  • C. diff infections in children range from mild diarrhea to severe conditions like pseudomembranous colitis and toxic megacolon.

Purpose of the Study:

  • To highlight the unique features of Clostridium difficile infections in pediatric patients.
  • To provide updated information and recommendations for pediatricians regarding C. diff infections in children.
  • To address the evolving epidemiology, including community-acquired infections and those in low-risk settings.

Main Methods:

  • This is a review article, synthesizing existing literature and epidemiological data.
  • Focuses on clinical presentations, diagnostic challenges, and management strategies specific to children.
  • Examines recent surveillance data on C. diff incidence and risk factors in pediatric populations.

Main Results:

  • The incidence and severity of C. diff infections in children are not fully understood, particularly in the 1-3 year age group.
  • Asymptomatic carriage is high in infants, but its clinical significance requires further clarification.
  • Recent trends show an increase in C. diff infections in the community, sometimes without typical risk factors like antibiotic use.

Conclusions:

  • Clostridium difficile poses a spectrum of disease risks in children, necessitating increased awareness and understanding.
  • Further research is needed to clarify the clinical significance of C. diff in young children and identify emerging risk factors.
  • Updated clinical guidance is crucial for pediatricians to effectively manage C. diff infections in this vulnerable population.

Related Concept Videos

Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid...
10
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
705
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
664
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
893
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
22
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.5K